Health Canada approves Pfizer’s COVID-19 vaccine for use as booster – CBC

Boosters have been recommended already for some higher-risk groups

Nov 09, 2021

Health Canada has approved a booster of Pfizer-BioNTech’s COVID-19 vaccine for people 18 years of age and older.

The booster is intended to help people who’ve had their first two COVID-19 vaccine doses to maintain their protection against the virus over time.

The booster is identical to the regular Pfizer-BioNTech vaccine and is to be administered at least six months after the second vaccine dose.

Different provinces have employed different rollout strategies for booster doses. The mRNA vaccines approved in Canada (Pfizer-BioNTech and Moderna) have been used already as a third dose to offer longer-lasting protection to high-risk people — including long-term care home residents and people who are immunocompromised — in several parts of the country.

Read more: https://www.cbc.ca/news/health/health-canada-pfizer-covid-vaccine-approved-booster-1.6242623